📚 其他文獻
High flow, at a higher cost? A pilot study comparing direct vs. indirect bypass for Moyamoya disease using time-driven activity-based costing.
BACKGROUND AND OBJECTIVE: In the management of adult moyamoya disease (MMD), there is clinical equip
Comorbidities in sickle cell disease by age in the Indiana sickle cell data collection (IN-SCDC).
OBJECTIVE: Survival for individuals with sickle cell disease (SCD) is increasing, and along with it
Occipital Artery-Posterior Cerebral Artery Bypass Combined With Encephalo-Duro-Pericranial Synangiosis for Posterior Circulation Ischemia in Adult Moyamoya Disease.
Integrative GWAS and snRNA-seq Reveal a Mesenchymal-Like Endothelial Signature in Moyamoya Disease.
BACKGROUND: Moyamoya disease (MMD) has a strong genetic basis, with the rare RNF213 p.Arg4810Lys var
Cerebral small vessel disease imaging markers and disease severity in moyamoya disease: Insights from magnetic resonance imaging analysis.
BACKGROUND: The clinical significance of the summary cerebral small vessel disease (CSVD) score in m
Safety and long-term outcomes following bypass surgery in pediatric versus adult patients with Moyamoya disease: a multicenter cohort study.
OBJECTIVE: Moyamoya disease (MMD) is a progressive cerebrovascular disorder and an important cause o
Reply to the Letter to the Editor: Intraoperative Cortical Indocyanine Green Extravasation as a Predictor of Cerebral Hyperperfusion following Direct Revascularization for Moyamoya Disease: Impact of Prolonged Observations of Indocyanine Green Videoangiography.
Clinical Translation of Ultrasound Localization Microscopy: A Narrative Review of Current Applications and Future Directions.
Microvascular dysfunction plays a pivotal role in numerous diseases, often preceding clinical sympto